[ Price : $8.95]
The Democratic 2012 platform is silent on any changes to be made to FDA.[ Price : $8.95]
Lilly Diabetes releases a free app for Glucagon users and their support network.[ Price : $8.95]
The Alliance for a Stronger FDA projects 2013 budget cuts under Congress sequestration could deliver a devastating blow to FDA and...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Boukhari Prince Medical BPM, Commed, DPT Lakewood, Infupharma, Merge Healthcare,...[ Price : $8.95]
FDA approves a higher dose of Novartis Exelon Patch (rivastigmine transdermal system) for treating people with mild to moderate Al...[ Price : $8.95]
FDA warns Prince Medical about Quality System and Medical Device Reporting violations in its French diagnostic catheter manufactur...[ Price : $8.95]
FDAs New Jersey District Office warns DPT Lakewood about CGMP violations in its manufacturing of Santyl ointment.[ Price : $8.95]
GBI Research says that companies are spending more on research and development but have fewer new products to show for it.